GLUE logo

Monte Rosa Therapeutics, Inc. (GLUE) Debt To Equity Ratio

Annual Debt To Equity:

0.19-0.07(-26.92%)
December 31, 2024

Summary

  • As of today, GLUE annual debt to equity ratio is 0.19, with the most recent change of -0.07 (-26.92%) on December 31, 2024.
  • During the last 3 years, GLUE annual debt to equity has risen by +0.19 (+100.00%).
  • GLUE annual debt to equity is now -26.92% below its all-time high of 0.26, reached on December 31, 2023.

Performance

GLUE Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGLUEfinancial health metrics

Quarterly Debt To Equity:

0.16+0.01(+6.67%)
September 30, 2025

Summary

  • As of today, GLUE quarterly debt to equity ratio is 0.16, with the most recent change of +0.01 (+6.67%) on September 30, 2025.
  • Over the past year, GLUE quarterly debt to equity has dropped by -0.05 (-23.81%).
  • GLUE quarterly debt to equity is now -46.67% below its all-time high of 0.30, reached on March 31, 2024.

Performance

GLUE Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGLUEfinancial health metrics

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

GLUE Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-26.9%-23.8%
3Y3 Years+100.0%0.0%
5Y5 Years+112.2%-

GLUE Debt To Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-26.9%>+9999.0%-46.7%+6.7%
5Y5-Year-26.9%+112.2%-46.7%+104.2%
All-TimeAll-Time-26.9%+112.2%-46.7%+104.2%

GLUE Debt To Equity History

DateAnnualQuarterly
Sep 2025
-
0.16(+6.7%)
Jun 2025
-
0.15(0.0%)
Mar 2025
-
0.15(-21.1%)
Dec 2024
0.19(-26.9%)
0.19(-9.5%)
Sep 2024
-
0.21(+5.0%)
Jun 2024
-
0.20(-33.3%)
Mar 2024
-
0.30(+15.4%)
Dec 2023
0.26
0.26(+4.0%)
Sep 2023
-
0.25(+13.6%)
Jun 2023
-
0.22(+15.8%)
DateAnnualQuarterly
Mar 2023
-
0.19(+11.8%)
Dec 2022
0.17(>+9900.0%)
0.17(+6.3%)
Sep 2022
-
0.16(0.0%)
Jun 2022
-
0.16(+700.0%)
Mar 2022
-
0.02(>+9900.0%)
Dec 2021
0.00(+100.0%)
0.00(0.0%)
Sep 2021
-
0.00(0.0%)
Jun 2021
-
0.00(+100.0%)
Mar 2021
-
-3.81(>-9900.0%)
Dec 2020
-1.39(+10.9%)
0.00
Dec 2019
-1.56
-

FAQ

  • What is Monte Rosa Therapeutics, Inc. annual debt to equity ratio?
  • What is the all-time high annual debt to equity for Monte Rosa Therapeutics, Inc.?
  • What is Monte Rosa Therapeutics, Inc. annual debt to equity year-on-year change?
  • What is Monte Rosa Therapeutics, Inc. quarterly debt to equity ratio?
  • What is the all-time high quarterly debt to equity for Monte Rosa Therapeutics, Inc.?
  • What is Monte Rosa Therapeutics, Inc. quarterly debt to equity year-on-year change?

What is Monte Rosa Therapeutics, Inc. annual debt to equity ratio?

The current annual debt to equity of GLUE is 0.19

What is the all-time high annual debt to equity for Monte Rosa Therapeutics, Inc.?

Monte Rosa Therapeutics, Inc. all-time high annual debt to equity ratio is 0.26

What is Monte Rosa Therapeutics, Inc. annual debt to equity year-on-year change?

Over the past year, GLUE annual debt to equity ratio has changed by -0.07 (-26.92%)

What is Monte Rosa Therapeutics, Inc. quarterly debt to equity ratio?

The current quarterly debt to equity of GLUE is 0.16

What is the all-time high quarterly debt to equity for Monte Rosa Therapeutics, Inc.?

Monte Rosa Therapeutics, Inc. all-time high quarterly debt to equity ratio is 0.30

What is Monte Rosa Therapeutics, Inc. quarterly debt to equity year-on-year change?

Over the past year, GLUE quarterly debt to equity ratio has changed by -0.05 (-23.81%)
On this page